Developing phytocompound-based new drugs against multi-drug-resistant Staphylococcus aureus.

Area of Science:

• Biochemistry
• Computational Biology
• Pharmacology

Background:

• Staphylococcus aureus is a common bacterium causing infections from mild to severe.
• Existing treatments face challenges, driving the need for novel therapeutic strategies.
• Targeting bacterial virulence factors, like Staphopain B, is a promising approach.

Purpose of the Study:

• To identify phytocompounds with therapeutic potential against Staphylococcus aureus.
• To evaluate the binding affinity of phytocompounds to the Staphopain B protein.
• To assess the antibacterial activity of neem leaf extracts.

Main Methods:

• Computational screening of 115 phytocompounds against Staphopain B.
• Molecular dynamic simulations (MDS) to assess protein-ligand stability.
• In vitro disc-diffusion assays using neem leaf extracts.

Main Results:

• Twelve phytocompounds exhibited drug-like properties.
• Nine compounds showed higher binding affinity to Staphopain B than doxycycline.
• Epoxyazadiradione and nimbolide demonstrated significant binding affinity and stability.
• Neem leaf extracts showed limited antibacterial inhibition compared to doxycycline.

Conclusions:

• Phytocompounds, particularly epoxyazadiradione and nimbolide, show promise as anti-Staphylococcus aureus agents.
• Targeting Staphopain B with these compounds is a viable therapeutic strategy.
• Further in vitro and in vivo studies are necessary to validate these findings.